BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 16403441)

  • 1. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M; McDannold N; Jolesz FA; Hynynen K
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1085-90. PubMed ID: 16403441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted drug delivery to the brain using focused ultrasound.
    Kinoshita M
    Top Magn Reson Imaging; 2006 Jun; 17(3):209-15. PubMed ID: 17414078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound, microbubbles and the blood-brain barrier.
    Meairs S; Alonso A
    Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.
    Huang Q; Deng J; Wang F; Chen S; Liu Y; Wang Z; Wang Z; Cheng Y
    Exp Neurol; 2012 Jan; 233(1):350-6. PubMed ID: 22079586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model.
    Xie F; Boska MD; Lof J; Uberti MG; Tsutsui JM; Porter TR
    Ultrasound Med Biol; 2008 Dec; 34(12):2028-34. PubMed ID: 18692294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular delivery across the blood-brain barrier.
    Hynynen K
    Methods Mol Biol; 2009; 480():175-85. PubMed ID: 19085123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging.
    Liu HL; Wai YY; Chen WS; Chen JC; Hsu PH; Wu XY; Huang WC; Yen TC; Wang JJ
    Ultrasound Med Biol; 2008 Apr; 34(4):598-606. PubMed ID: 18313204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ; de Boer AG
    Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
    Yang FY; Lin YS; Kang KH; Chao TK
    J Control Release; 2011 Feb; 150(1):111-6. PubMed ID: 21070825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA
    Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical drug targeting to the brain.
    Pardridge WM
    J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity.
    McDannold N; Vykhodtseva N; Hynynen K
    Phys Med Biol; 2006 Feb; 51(4):793-807. PubMed ID: 16467579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M; Fortin D
    Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.